Intradermal pre-exposure rabies vaccine elicits long lasting immunity

Vaccine

Volumn 26, Issue 31, 2008, Pages 3909-3912

  Brown, David ^a   Featherstone, John J ^b   Fooks, Anthony R ^b,c   Gettner, Sharmeen ^a   Lloyd, Elizabeth ^d   Schweiger, Martin ^e  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b Wakefield ^*  (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e West Yorkshire Health Protection Unit   (United Kingdom)

Author keywords

Immunisation; Immunity; Intradermal; Rabies

Indexed keywords

RABIES VACCINE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RABIES; SEROCONVERSION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; RABIES; RABIES VACCINES; RETROSPECTIVE STUDIES;

EID: 46349084469     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.081     Document Type: Article

References (15)

1. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th Edition (2004), WB Saunders Company, Philadelphia
2. BMJ Publishing, Royal Pharmaceutical Society Publishing (2007) British National Formulary. Available from: www.bnf.org (accessed on 19/7/07).
3. Bernard K.W., Roberts M.A., Sumner J., Winkler W.G., Mallonee J., Baer G.M., et al. Human diploid cell rabies vaccine effectiveness of immunization with small intradermal or subcutaneous doses. JAMA 247 8 (1982) 1138-1142
4. Phanuphak P., Khawplod P., Sirivichayakul S., Siriprasomsub W., Ubol S., and Thaweepathomwat M. Humoral and cell-mediated immune responses to various economical regimens of purified Vero cell rabies vaccine. Asian Pacific J Allergy Immunol 5 1 (1987) 33-37 (launched by the Allergy and Immunology Society of Thailand)
5. Turner G.S., Aoki F.Y., Nicholson K.G., Tyrrell D.A., and Hill L.E. Human diploid cell strain rabies vaccine Rapid prophylactic immunisation of volunteers with small doses. Lancet 1 7974 (1976) 1379-1381
6. Warrell M.J., Suntharasamai P., Nicholson K.G., Warrell D.A., Chanthavanich P., Viravan C., et al. Multi-site intradermal and multi-site subcutaneous rabies vaccination: improved economical regimens. Lancet 1 8382 (1984) 874-876
7. Lau C., and Sisson J. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J. Travel Med: Official Publ Int Soc Travel Med Asia Pacific Travel Health Assoc 9 6 (2002) 285-288
8. Bernard K.W., Fishbein D.B., Miller K.D., Parker R.A., Waterman S., Sumner J., et al. Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries. Am J Trop Med Hyg 34 3 (1985) 633-647
9. Lemon S.M., Miller R.N., Pang L.W., Prier R.E., and Bernard K.W. Failure to achieve predicted antibody responses with intradermal and intramuscular human diploid cell rabies vaccine. Lancet 1 8386 (1984) 1098-1100
10. Current trends field evaluations of pre-exposure use of human diploid cell rabies vaccine. Morbidity and Mortality Weekly Report. Centre for Disease Control and Prevention 1983;32(46):601-3.
11. Fishbein D.B., Pacer R.E., Holmes D.F., Ley A.B., Yager P., and Tong T.C. Rabies preexposure prophylaxis with human diploid cell rabies vaccine: a dose-response study. J Infect Dis 156 1 (1987) 50-55
12. Sabchareon A., Chantavanich P., Pasuralertsakul S., Pojjaroen A., Prarinyanupharb V., Attanath P., et al. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 17 11 (1998) 1001-1007
13. Cliquet F., Aubert M., and Sagnq L. Development of a fluorescent antibody virus neutralisation test FAVN test for the quantitation of rabies-neutralising antibody. J Immunol Methods 212 1 (1998) 79-87
14. WHO (2004) World Health Organization Expert Consultation on rabies. WHO Technical Report Series 931 First Report Available from http://www.wpro.who.int/NR/rdonlyres/B1ED8443-0993-408C-BF09-D1D06A6E1B4 5/0/FINALTEXTWHOTechnicalReportSeries090605.pdf (accessed 27.10.07).
15. Strady C, Jaussaud R, Béguinot I, Lienard M, Strady A. Predictive factors for the neutralizing antibody response following pre-exposure rabies immunization: validation of a new booster dose strategy. Vaccine, 2000;18(24):2661-7.